We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Should You Buy Neil Woodford’s China-Proof Shares Imperial Tobacco Group PLC, AstraZeneca plc And BT Group plc?

Neil Woodford’s top holdings Imperial Tobacco Group PLC (LON:IMT), AstraZeneca plc (LON:AZN) and BT Group plc (LON:BT.A) are an antidote to his concerns about China.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Renowned fund manager Neil Woodford has been concerned for some time about the Chinese economy, and what it means for the global economy as a whole. He discusses the subject in some detail in a blog post today.

Woodford suggests that recent growth figures coming out of China have lacked credibility when compared with other real economic data, noting:

XXX

“Even the Chinese Premier, Li Keqiang, allegedly mistrusts the country’s official economic statistics, preferring to track growth by looking at real data. The Li Keqiang Index, as it has become known, tracks growth in outstanding bank loans, electricity production and rail freight volumes, and currently shows a reading of just 2.5% year-on-year. It last visited that level in November 2008, just after Lehman collapsed”.

Woodford suggests that the number of reasons to be cautious about China is increasing. He particularly highlights what will be an inevitably long and bumpy transition from heavy infrastructure investment to a more Western consumption-based economy. Furthermore, he reckons the State is struggling to adopt the required political approach for such a transition, as demonstrated by recent interventions in the stock and currency markets.

The level of private sector debt in the Chinese economy is another big concern Woodford highlights. He says the level is “alarming” and suggests that the Chinese economy will have to go through “a period of prolonged debt moderation”. He also notes that China has scope to lower interest rates, which could export deflation to the rest of the world, with “signification ramifications for the global economic outlook”.

Woodford-watchers will know he has been concerned about the risks emanating from China for some years, and has built his portfolios in the expectation that there’ll be little help from macroeconomic tailwinds. As such, he has populated his portfolios with companies that are more in control of their own destinies — avoiding, oil companies, miners and banks.

The top holding in Woodford’s equity income fund, Imperial Tobacco (LSE: IMT), is a prime example of a company more in control of its own destiny. Tobacco consumption is not really dependent on buoyant economies. The industry does face some headwinds, caused by increased health awareness in developed countries, but Woodford reckons the prospects and cash-generative qualities of tobacco companies continue to be under-appreciated by the market. Imperial trades on a forward P/E of 15 and offers a prospective 4.4% dividend yield, which looks attractive for such a “defensive” company.

Woodford’s no. two holding AstraZeneca (LSE: AZN) may be at the other end of the health spectrum to Imperial, but it also has solid defensive qualities. In addition, the big pharma company should benefit from demographic trends of ageing populations. Woodford believes Astra did the right thing in rejecting a £55 a share takeover bid by US giant Pfizer last year. With the shares now trading at under £42 (forward P/E 16, yield 4.2%) you have an idea of how much value Woodford sees in the company.

BT (LSE: BT-A) is another of Woodford’s top five holdings. Increasingly, packages of fixed line, mobile, broadband and pay-TV are becoming more of a staple for consumers than a luxury. BT’s agreed acquisition of mobile group EE will extend the group’s capabilities, and, after some initial concerns, Woodford decided that the acquisition was a good move for BT and its shareholders. If he’s right, BT’s current forward P/E of 13 and yield of 3.5% represent excellent value.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Friends and sisters exploring the outdoors together in Cornwall. They are standing with their arms around each other at the coast.
Investing Articles

£503 buys 14 shares in this FTSE 250 stock that returned 23.9% annually for the last 15 years

This FTSE 250 stock has averaged a huge return for 15 years. At today's price, £503 buys 14 shares. But…

Read more »

Black woman using loudspeaker to be heard
Investing Articles

£1,000 buys 25 shares in this FTSE 100 stock that’s returned 29.2% annually for the last 10 years

This FTSE 100 mining stock has returned close to 30% a year for a decade. At 3,995p, £1,000 buys 25…

Read more »

Female student sitting at the steps and using laptop
Investing Articles

Down 47%, is this growth stock finally worth buying in May?

With a £288m order book and a hidden pipeline of defence and nuclear contracts, is this growth stock now too…

Read more »

House models and one with REIT - standing for real estate investment trust - written on it.
Investing Articles

2 REITs yielding 7%+ to consider for passive income in 2026

A REIT backed by the NHS and another backed by Tesco and Sainsbury's with both yielding 7%+. Here's why I'm…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Just 97 shares of this UK dividend stock generate £238 in passive income

A 5.7% yield, £238 in passive income from just 97 shares, and one of the most divisive dividend stocks on…

Read more »

ISA coins
Investing Articles

£10,000 in an ISA generates a second income of…

The London Stock Exchange is home to some of the world's most generous dividends. But how big a second income…

Read more »

Shot of a senior man drinking coffee and looking thoughtfully out of a window
Investing Articles

Expert recommendations: 2 top income stocks yielding 7%+!

With yields of 7.2% and 7.8% respectively, these two income stocks are catching the eyes of institutional analysts. Should investors…

Read more »

Illustration of flames over a black background
Investing Articles

3 top income-focused stocks to buy in May 2026, according to experts

Looking for a stock to buy for income in May 2026? Experts have flagged these three UK dividend shares as…

Read more »